Cancer Drug Firm Ducks Shareholder Suit Over $26M Offering

Cancer Drug Firm Ducks Shareholder Suit Over $26M Offering

A putative class action lawsuit accusing GenVec Inc. of raising $26.2 million from shareholders to develop a pancreatic cancer treatment it knew to be ineffective was dismissed from a Maryland federal court on Friday, because the biopharmaceutical company ...read more

  • Tags: